We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Development, Implementation and Evaluation of the Impact of a Guideline in Clinical Practise for Cardiovascular Risk

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01270022
Recruitment Status : Completed
First Posted : January 5, 2011
Last Update Posted : January 5, 2011
Information provided by:

Study Description
Brief Summary:
The aim of this study is to evaluate the impact of a clinical guideline in cardiovascular risk, with a local adaptation model of the existing guidelines in clinical practise at present, of each of the different cardiovascular risk factors, and the implementation strategy.

Condition or disease Intervention/treatment
Cardiovascular Risk Factors Clinical Practice Guideline Implementation Strategies Primary Care Other: Implementation Other: dissemination

Detailed Description:

With this objective this study will be developed in three diferent phases. The guideline in clinical practice elaboration. It will be based in evidence medicine and it will be adapted based in the cardiovascular risk factors guidelines published at the present.

The spreding and implementation of the guideline between the sanitarians, as much in primary medicine as in specialised area, involved in the care of the patient in cardiovascular risk, in the Area 2 in Madrid.

And the evaluation of the implementation strategy, used between the primary care physicians.

For the local adaptation, will be used a systematic review of the different guidelines in the Spanish and international literature, published in the last years about this topic.

The ones with better quality criteria will be selected and doctors and nurses related from different specialities, involved in the cardiovascular illness, as much as members of the staff of the medical management an nursery, will be invited to participate in the selection of the recommendations of the guides and in the search of the consensus. After that, this guide will be given to a group of patients, who will be asked for a critical approach and their suggestions will be applied.

The evaluation will be done with a clinical trial designe , testing the use of the guide and its results on health intermediary variables. With this objective the results with an implementation technique based on opinion leaders plus computer reminder, will be evaluated, instead of using the standard implementation.

Study Design

Study Type : Interventional  (Clinical Trial)
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Triple (Participant, Care Provider, Investigator)
Primary Purpose: Health Services Research
Official Title: Development, Implementation and Evaluation of the Impact of a Guideline in Clinical Practise for Cardiovascular Risk.
Study Start Date : January 2004
Primary Completion Date : April 2006
Study Completion Date : July 2010
Arms and Interventions

Arm Intervention/treatment
Experimental: Implementation Other: Implementation
Active Comparator: dissemination Other: dissemination

Outcome Measures

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   14 Years and older   (Child, Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • patients whose health cards showed them to belong to the studied health area

Exclusion Criteria:

  • Clinical history have not opened in the health center or this one is empty
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01270022

Gerencia de Atención Primaria del área 2
Madrid, Spain, 28009
Sponsors and Collaborators
Gerencia De Atencion Primaria Area 2 De Madrid
Health Research Fund of ISCIII Spain
Principal Investigator: Blanca Novella, MD. pHD Gerencia de Atención Primaria del área 2